Stock Scorer

Chemours Co (CC)

Chemours Co reported revenue of 1.6B USD for the quarter ending 30 June 2026, down 1.5% from 1.6B a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 1.6B -1.5%
Gross Profit Q2 '26 · ending 30 June 2026 286M +2.9%
Net Income Q2 '26 · ending 30 June 2026 -274M —
Cost of Revenue Q2 '26 · ending 30 June 2026 1.3B -2.4%
Operating Cash Flow Q2 '26 · ending 30 June 2026 158M +69.9%
Free Cash Flow Q2 '26 · ending 30 June 2026 114M +128.0%
Shares Outstanding Q2 '26 · ending 30 June 2026 151.2M +0.9%
EPS Q2 '26 · ending 30 June 2026 -1.91 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 5.8B—-386M51M
20242024-12-31 5.8B—69M-993M
20232023-12-31 6.1B—-253M186M
20222022-12-31 6.8B—578M448M
20212021-12-31 6.3B—608M537M
20202020-12-31 5B—219M540M
20192019-12-31 5.5B—-52M169M
20182018-12-31 6.6B—995M642M
20172017-12-31 6.2B—746M229M
20162016-12-31 5.4B—7M256M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-301.6B
Q1 '262026-03-311.4B
Q4 '252025-12-311.3B
Q3 '252025-09-301.5B
Q2 '252025-06-301.6B
Q1 '252025-03-311.4B
Q4 '242024-12-311.4B
Q3 '242024-09-301.5B
Q2 '242024-06-301.6B
Q1 '242024-03-311.4B
Q4 '232023-12-311.4B
Q3 '232023-09-301.5B
Q2 '232023-06-301.6B
Q1 '232023-03-311.5B
Q4 '222022-12-311.3B
Q3 '222022-09-301.8B
Q2 '222022-06-301.9B
Q1 '222022-03-311.8B
Q4 '212021-12-311.6B
Q3 '212021-09-301.7B

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30286M
Q1 '262026-03-31212M
Q4 '252025-12-31156M
Q3 '252025-09-30233M
Q2 '252025-06-30278M
Q1 '252025-03-31236M
Q4 '242024-12-31265M
Q3 '242024-09-30286M
Q2 '242024-06-30308M
Q1 '242024-03-31284M
Q4 '232023-12-31251M
Q3 '232023-09-30273M
Q2 '232023-06-30410M
Q1 '232023-03-31368M
Q4 '222022-12-31202M
Q3 '222022-09-30432M
Q2 '222022-06-30497M
Q1 '222022-03-31486M
Q4 '212021-12-31393M
Q3 '212021-09-30427M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-274M
Q1 '262026-03-31-29M
Q4 '252025-12-31-47M
Q3 '252025-09-3060M
Q2 '252025-06-30-380M
Q1 '252025-03-31-5M
Q4 '242024-12-31-11M
Q3 '242024-09-30-32M
Q2 '242024-06-3060M
Q1 '242024-03-3154M
Q4 '232023-12-31-18M
Q3 '232023-09-3012M
Q2 '232023-06-30-376M
Q1 '232023-03-31145M
Q4 '222022-12-31-97M
Q3 '222022-09-30240M
Q2 '222022-06-30201M
Q1 '222022-03-31234M
Q4 '212021-12-31233M
Q3 '212021-09-30214M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-301.3B
Q1 '262026-03-311.2B
Q4 '252025-12-311.2B
Q3 '252025-09-301.3B
Q2 '252025-06-301.3B
Q1 '252025-03-311.1B
Q4 '242024-12-311.1B
Q3 '242024-09-301.2B
Q2 '242024-06-301.2B
Q1 '242024-03-311.1B
Q4 '232023-12-311.1B
Q3 '232023-09-301.2B
Q2 '232023-06-301.2B
Q1 '232023-03-311.2B
Q4 '222022-12-311.1B
Q3 '222022-09-301.3B
Q2 '222022-06-301.4B
Q1 '222022-03-311.3B
Q4 '212021-12-311.2B
Q3 '212021-09-301.3B

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30158M
Q1 '262026-03-31-44M
Q4 '252025-12-31137M
Q3 '252025-09-30146M
Q2 '252025-06-3093M
Q1 '252025-03-31-112M
Q4 '242024-12-31138M
Q3 '242024-09-30139M
Q2 '242024-06-30-620M
Q1 '242024-03-31-290M
Q4 '232023-12-31482M
Q3 '232023-09-30131M
Q2 '232023-06-3067M
Q1 '232023-03-31-124M
Q4 '222022-12-31161M
Q3 '222022-09-30301M
Q2 '222022-06-30291M
Q1 '222022-03-312M
Q4 '212021-12-31208M
Q3 '212021-09-30311M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30114M
Q1 '262026-03-31-93M
Q4 '252025-12-3192M
Q3 '252025-09-30105M
Q2 '252025-06-3050M
Q1 '252025-03-31-196M
Q4 '242024-12-3129M
Q3 '242024-09-3063M
Q2 '242024-06-30-693M
Q1 '242024-03-31-392M
Q4 '232023-12-31347M
Q3 '232023-09-3045M
Q2 '232023-06-309M
Q1 '232023-03-31-215M
Q4 '222022-12-3194M
Q3 '222022-09-30229M
Q2 '222022-06-30229M
Q1 '222022-03-31-104M
Q4 '212021-12-31125M
Q3 '212021-09-30244M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-30151.2M
Q1 '262026-03-31150.8M
Q3 '252025-09-30150.8M
Q2 '252025-06-30150.2M
Q1 '252025-03-31149.9M
Q3 '242024-09-30149.7M
Q2 '242024-06-30150.1M
Q1 '242024-03-31150.1M
Q3 '232023-09-30150.2M
Q2 '232023-06-30149.1M
Q1 '232023-03-31151.2M
Q3 '222022-09-30157.9M
Q2 '222022-06-30159.7M
Q1 '222022-03-31163.6M
Q3 '212021-09-30169M
Q2 '212021-06-30170.2M
Q1 '212021-03-31169.1M
Q3 '202020-09-30166.6M
Q2 '202020-06-30165.4M
Q1 '202020-03-31165.3M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-1.91
Q1 '262026-03-31-2.63
Q4 '252025-12-31-2.47
Q3 '252025-09-30-2.24
Q2 '252025-06-30-2.86
Q1 '252025-03-310.06
Q4 '242024-12-310.45
Q3 '242024-09-300.41
Q2 '242024-06-300.71
Q1 '242024-03-31-2.20
Q4 '232023-12-31-1.60
Q3 '232023-09-30-2.13
Q2 '232023-06-30-0.69
Q1 '232023-03-313.09
Q4 '222022-12-313.56
Q3 '222022-09-305.60
Q2 '222022-06-305.35
Q1 '222022-03-314.48
Q4 '212021-12-313.62
Q3 '212021-09-302.34